Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset

By Gnanalingham K.K.   Milkowski N.A.   Smith L.A.   Hunter A.J.   Jenner P.   Marsden C.D.  

European Journal of Pharmacology, Vol. 277, Iss. 2, 1995-04 ,pp. : 235-241

Elsevier

Access to resources Recommend Favorite

Dopamine D 1 receptor desensitization profile in MPTP-lesioned primates

By Blanchet P.J.   Grondin R.   Bedard P.J.   Shiosaki K.   Britton D.R.  

European Journal of Pharmacology, Vol. 309, Iss. 1, 1996-08 ,pp. : 13-20

Elsevier

Access to resources Recommend Favorite

Dopamine D 1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958

By Grondin R.   Goulet M.   Morissette M.   Bedard P.J.   Di Paolo T.  

European Journal of Pharmacology, Vol. 378, Iss. 3, 1999-08 ,pp. : 259-263

Elsevier

Access to resources Recommend Favorite

Studies of four novel diphenylbutylpiperazinepyridyl derivatives on release and inhibition of reuptake of dopamine, serotonin and noradrenaline by rat brain in vitro

By Pettersson E.  

European Journal of Pharmacology, Vol. 282, Iss. 1, 1995-08 ,pp. : 131-135

Elsevier

Access to resources Recommend Favorite

No change in striatal dopamine re-uptake site density in psychotropic drug naive and in currently treated Tourette's disorder patients: a [ 123 I]- -CIT SPECT-study

By Stamenkovic M.   Schindler S.D.   Asenbaum S.   Neumeister A.   Willeit M.   Willinger U.   de Zwaan M.   Riederer F.   Aschauer H.N.   Kasper S.  

European Neuropsychopharmacology, Vol. 11, Iss. 1, 2001-02 ,pp. : 69-74

Elsevier

Access to resources Recommend Favorite